Benitec Biopharma Inc.
BNTC· Nasdaq
BNTCBenitec Biopharma Inc.
Filed Sep 2, 2022 · 10-K · 64 days after period end · 0001193125-22-237075
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|
| Revenue | $0.00 | $2.00K | — |
| Net Income | -$5.07M | -$4.00M | -$2.94M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Benitec Biopharma Inc. · CIK 1808898 · Engraved from SEC EDGAR
ended Jun 30, 2022 · filed Sep 2, 2022 · 64 d after period end
